ClinicalTrials.gg
Enrolling by invitationNCT06917703Updated Jan 6, 2026

Effectiveness of a Mobile Health Program in Pregnant Women

An interventional study of E-learning in Pregnancy, Gestational Age and Weight Conditions and Eating Behaviors, sponsored by National Taipei University of Nursing and Health Sciences. Enrolling by invitation at 1 site in Taiwan. Open to female participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-06.

Sponsored by National Taipei University of Nursing and Health Sciences · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Primary completion was expected by Jun 2026, 4 months ago, but the record still lists the study as enrolling by invitation.
Phase
Not applicable
Study type
Interventional
Enrollment
160
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
Female
01

Study summary

  1. To evaluate the usability and user experience of the i-PregMom mobile application and digital dietary image recording among pregnant women.
  2. To examine the effectiveness of digital mobile health interventions on blood glucose levels and gestational weight gain among pregnant women from 10-14 weeks to 24-28 weeks of gestation.
Read the detailed description
  1. Sociodemographic variables: age, education level, marital status, occupation, and socioeconomic status.
  2. Obstetric variables: gravidity, history of miscarriage, pregnancy complications, and mode of delivery.
  3. Pre-pregnancy BMI.
  4. Dietary habits, perceived healthy eating behaviors, and dietary patterns.
  5. Psychological distress and depressive symptoms.
  6. Gestational blood glucose levels and GWG
02

Conditions studied

  • Pregnancy
  • Gestational Age and Weight Conditions
  • Eating Behaviors
  • Literacy
  • E-learning

Keywords

  • pregnancy
  • health literacy
  • E-learning
  • gestational weight gains
  • nutriention
03

In context

Feeding Behavior

985 studies on the registry are indexed under Feeding Behavior; 178 are open to participants now.

This study's planned enrollment of 160 is above the median of 77 across 700 interventional studies indexed under Feeding Behavior.

Browse Feeding Behavior studies →

Lead sponsor

National Taipei University of Nursing and Health Sciences is the lead sponsor of 124 studies on the registry; 23 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Primiparous women aged ≥18 years.

Singleton pregnancy.

Pregnant women between 10 and 14 weeks of gestation, with gestational age calculated based on the first day of the last menstrual period.

Able to listen, speak, read, and write in Chinese.

Willing to provide prenatal weight and blood glucose data.

Possess a mobile communication device (such as a smartphone or social media account) and be able to receive emails.

Exclusion criteria

Exclusion Criteria:

  • Engaged in weight loss activities prior to pregnancy.

Diagnosed with chronic illnesses that may affect weight changes (e.g., psychiatric disorders, thyroid diseases).

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Care provider)
Enrollment
160 participants (estimated)

Study arms

  • Experimental
    Mobile Health Program

    The intervention group will receive face-to-face nutrition education (15-30 min/session) based on the Health Promotion Administration's pregnancy dietary guidelines and access to the i-PregMom mobile application for continuous dietary management.

    Other: E-learning

  • No intervention
    rountine care

    The control group will receive only face-to-face nutrition education (15-30 min/session) based on standard pregnancy dietary guidelines.

Interventions

  • OtherE-learning

    in experience group

06

What researchers measure

Primary outcomes

  1. Gestational Weight Gain in Pregnant

    Gestational Weight Gain (GWG) will be recorded three times (10-14, 12-16, and 24-28 weeks of gestation) based on maternity health records to analyze trends in weight changes and the impact of the mobile health intervention.

    Time frame: o Gestational Weight Gain (GWG) will be recorded three times (10-14, 12-16, and 24-28 weeks of gestation) based on maternity health records to analyze trends in weight changes and the impact of the mobile health intervention.

07

Study locations

1 site
  • 365, Ming-Te Rd, Peitou District, Taipei 11219, Taiwan, ROC
    Taipei, Taiwan 11219, Taiwan
08

References and documents

Individual participant data

Plan to share: No — The data will be anonymized and used solely for analysis in preparation for publication; it will not be shared."

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06917703
Collaborators
Ministry of Science and Technology, Taiwan
Responsible party
Tzu-Ling Chen (Associate Professor, National Taipei University of Nursing and Health Sciences) — Principal investigator
First posted
Apr 8, 2025
Start date
Apr 11, 2025
Primary completion
Jun 30, 2026 (estimated)
Completion
Oct 30, 2026 (estimated)
Last update
Jan 6, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion